“We lack a more comprehensive view of patients who are not hospitalized,” added Joana Sousa, a consultant at MOAI Consulting, who presented some national data and a comparison of strategies across various countries to help us understand how investing in prevention “is the most effective strategy in public health, helping to reduce hospitalizations, emergency room visits, and the consumption of many resources, with significant economic implications.”
Translated with DeepL.com (free version)
Observador published the results and recommendations discussed at the “Forum for Innovation in Pneumococcal Disease”, organised by MSD Portugal, with the participation of scientific leaders, health authorities, patient organisations, and other stakeholders, and with technical support by MOAI Consulting.
At MOAI, we believe that effective public health policies must be supported by reliable evidence and coordinated action. Through the development of robust studies and the analysis of health, economic, and epidemiological data, MOAI supports stakeholders in generating the evidence needed to strengthen prevention strategies, reduce infections and hospitalisations, limit emergency department visits, ease pressure on healthcare professionals, and address the wider economic and social burden of pneumococcal disease.
